Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > keeler and lou
View:
Post by 1oldguy1 on Jun 03, 2024 8:39am

keeler and lou

twins ,  that make me laugh
Comment by BrokerG on Jun 03, 2024 9:48am
So we are now down 45% from the rescheduling announcement and dropping. Furthermore, I guess the market did NOT like the quarterly report since we have been dropping since then. From what I read and analyzed I thought the quarterly was ok and positive. Am I reading this wrong? What is going on with this stock? Rescheduling discussion window will be over by July 22/24. 
Comment by charlie007 on Jun 03, 2024 10:20am
Key Takeaways. Canopy Growth's consolidated net revenue for Q4 FY24 was $73 million, a 16% increase year-over-year. Gross margin improved to 21%, while adjusted EBITDA loss reduced to $15 million, a 63% improvement. The company reduced its debt by over $700 million and divested non-core assets. Based on analyst ratings, Canopy Growth's 12-month average price target is $6.32 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities